YOLFTbeta
Komipharm International Co. Ltd

Komipharm International Co. Ltd

041960 · KQ · Healthcare / Pharmaceuticals

8,410.00KRW-180.00 (-2.10%)

Price History

Full chart

Market Stats

Previous Close8,590.00
Open8,530.00
Day Range8,360.00 – 8,660.00
52-Week Range5,650.00 – 10,790.00
Volume93.28K
Market Cap710.89B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.09
50-Day Avg8,941.60
200-Day Avg8,313.20

About

Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. It also develops anticancer drugs and pain-relieving agents, which include Kominox, an arsenic-based oral drug; and Panaphix, a non-narcotic cancer pain reliever, as well as provides clinical pathological experiment, test, and analysis services. The company was formerly known as Korea Microbiological Laboratories Co., Ltd. and changed its name to Komipharm International Co., Ltd. in September 2004. The company was founded in 1972 and is headquartered in Siheung, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Seong-Cheol Moon
  • Employees150
  • Headquarters17, Gyeongje-Ro, Siheung-Si, South Korea, Korea
  • Websitehttps://www.komipharm.co.kr

Leadership

  • Mr. Seong-Cheol MoonChief Exec. Officer and Pres · b. 1959
  • Sang-Hyun KimExec. Officer
  • Yi-Geun ParkExec. Officer · b. 1967
  • Yong-Jin YangChairperson, Chief Exec. Officer and Pres · b. 1953
  • Jung-Yeon HwangSr. Managing Director · b. 1951
  • Kyung-Ho YooManaging Director

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue20.30B22.11B26.46B34.45B36.41B37.64B36.64B34.99B35.49B37.16B35.85B39.80B42.65B58.78B52.47B
Growth (%)-+8.91%+19.69%+30.19%+5.66%+3.38%-2.64%-4.49%+1.42%+4.71%-3.53%+11.03%+7.15%+37.83%-10.74%
Cost of Revenue11.44B12.89B16.68B21.98B25.38B26.68B25.05B25.22B24.07B23.78B24.61B28.34B29.99B37.01B35.41B
Gross Profit---11.20B11.03B10.96B11.60B9.78B11.42B13.38B11.23B11.46B12.66B21.76B17.06B
Gross Margin---32.51%30.29%29.12%31.65%27.94%32.17%36.00%31.34%28.79%29.68%37.03%32.51%
Operating Expense---11.02B12.49B10.97B21.63B27.25B24.05B15.55B16.88B15.45B19.03B16.81B15.10B
Operating Income138.40M664.75M472.43M177.68M-1.46B-10.84M-10.03B-17.47B-12.64B-2.17B-5.64B-3.99B-6.37B4.96B1.96B
Operating Margin0.68%3.01%1.79%0.52%-4.01%-0.03%-27.38%-49.92%-35.60%-5.85%-15.74%-10.02%-14.94%8.43%3.74%
EBITDA------------1.44B341.75M21.00B-2.50B
EBITDA Margin------------3.61%0.80%35.72%-4.76%
Net Income-1.01B--2.15B-6.55B289.39M-5.10B-14.30B-21.36B-2.82B-4.46B-6.51B-3.98B13.11B-7.21B
Net Income Margin-4.57%--6.24%-17.99%0.77%-13.91%-40.87%-60.20%-7.58%-12.44%-16.37%-9.33%22.31%-13.74%
R&D788.67M-3.84B2.96B51.39M152.40M40.84M2.76B4.65B3.27B5.12B2.54B5.94B2.47B1.63B
R&D as % of Total Revenue3.88%-14.51%8.60%0.14%0.40%0.11%7.88%13.10%8.79%14.28%6.37%13.94%4.20%3.11%
Interest Expense000000002.10B1.55B1.66B2.22B2.55B3.21B2.60B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.91%4.17%4.62%5.57%5.98%5.45%4.95%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets64.12B76.98B108.80B124.40B133.39B149.84B149.27B139.90B125.64B121.91B115.26B111.75B118.60B122.77B133.92B
Total Liabilities24.88B36.41B64.08B71.24B57.26B56.64B48.00B46.52B52.37B45.64B48.80B51.12B58.58B57.23B61.86B
Total Equity39.24B40.56B44.72B53.16B76.13B93.20B101.27B93.39B73.28B76.28B66.46B60.63B56.34B62.28B69.54B
Cash12.08B7.59B1.65B6.53B12.87B26.84B27.58B19.17B18.87B15.05B2.08M1.44M14.82B12.45B27.89B
Total Debt-----27.83B19.48B23.38B31.71B21.12B-----
Net Debt---------20.24B21.04B26.89B29.77B31.00B12.26B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--3.93B-2.54B-2.93B1.21B235.64M-2.02B950.79M25.20M-1.26B-1.81B-2.80B8.85B-621.80M
Investing Cash Flow----12.29B-6.02B-6.61B811.49M-12.35B-6.56B-1.57B-744.84M-1.38B-3.50B1.98B-
Financing Cash Flow17.05B10.40B25.61B19.69B15.22B18.96B317.26M7.17B5.36B-1.64B-1.02B2.03B10.53B-13.23B-
Capital Expenditure1.59B9.59B24.93B8.00B12.27B12.24B2.68B5.43B5.74B1.66B813.43M1.07B1.13B3.98B4.47B
Free Cash Flow----------1.66B-2.44B-2.87B-3.93B4.87B-5.09B
FCF to OCF----------6587.30%194.25%158.93%140.32%55.03%819.03%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 16, 2016Nov 14, 2016Feb 23, 2017May 15, 2017Aug 13, 2017Nov 13, 2017Feb 14, 2018Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019May 14, 2020Aug 13, 2020Nov 16, 2020Feb 19, 2021May 14, 2021Aug 13, 2021Nov 12, 2021Feb 17, 2022May 13, 2022Aug 12, 2022Nov 14, 2022Mar 15, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Feb 21, 2024May 10, 2024Aug 6, 2024Nov 12, 2024Feb 19, 2025May 14, 2025Aug 4, 2025Oct 31, 2025Dec 31, 2025May 12, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------------
EPS Actual7.70-18.84-6.67-33.9819.48-22.53-0.8814.863.145.27-14.576.609.21-7.28-0.533.0113.38-15.30-8.587.152.13-4.611.12-32.25-12.3211.41-40.71-55.8510.405.43-12.03-0.16-1.171.260.10-80.72-19.88-5.44-14.83-164.290.26-3.41-9.41-292.60-13.3614.81-15.27-30.4315.02-13.62-38.16-33.03-1.5317.32-15.37-102.60-12.97-10.35-22.18-14.4310.9572.8193.5410.990.68-45.36-2.11-54.3411.928.62
Surprise----------------------------------------------------------------------
Timing-----------------------------Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market---------------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap710.89B
Enterprise Value722.00B
Trailing P/E0.00
Forward P/E0.00
Price / Sales13.31
Price / Book9.88
Revenue (TTM)39.80B
Gross Profit (TTM)11.11B
EBITDA298.49M
Profit Margin-5.23%
Operating Margin-8.22%
Return on Equity2077.31%
Return on Assets-1.75%
Shares Outstanding57.81M
Shares Float42.68M
Beta-0.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20031×
18.45Dec 29, 2003
20021×
6.15Dec 27, 2002

Stock Splits

  • Aug 17, 2023798:725
  • Jul 11, 201911:10
  • Dec 27, 201821:20
  • Apr 27, 20115:1
  • Dec 27, 2007929:778
  • Dec 28, 200521:20
  • Dec 29, 200451:50